Despite Downturn, Investment Firm Survey Sees Emerging Uses for Microarrays | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Despite recent concerns about declining interest in and uses for microarray technology, the results of a survey conducted by investment firm William Blair suggest the technology still has a place in the research world, though likely in certain emerging applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.